Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Recruiting · NCT06806930 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) | Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, breast carcinoma, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-03-03 | NCT06806930 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| George Washington University | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| George Washington-Medical Faculty Associates | Washington D.C. | United States | 2 |